Kindred Biosciences, Inc.
(NASDAQ : KIN)

( )
KIN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
ZTSZoetis, Inc. 0.04%130.451.9%$309.46m
TEVATeva Pharmaceutical Industries Ltd. 1.62%12.522.0%$158.31m
MYLMylan NV 0.00%16.143.2%$107.74m
BBIOBridgeBio Pharma, Inc. 0.00%35.320.0%$17.01m
RDYDr. Reddy's Laboratories Ltd. -0.93%50.932.0%$10.95m
TXMDTherapeuticsMD, Inc. 2.46%1.2522.1%$8.18m
ABEOAbeona Therapeutics, Inc. 0.00%3.054.5%$3.72m
TAROTaro Pharmaceutical Industries Ltd. 0.35%69.326.5%$2.20m
LFVNLifeVantage Corp. 0.00%14.883.3%$1.95m
COCPCocrystal Pharma, Inc. -1.49%1.000.0%$1.84m
KINKindred Biosciences, Inc. 0.00%4.770.3%$1.46m
JAGXJaguar Health, Inc. -1.45%0.432.0%$0.67m
CPHIChina Pharma Holdings, Inc. -2.55%0.460.1%$0.46m

Company Profile

Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.